‌

US Patent 12129223 Lipids for use in lipid nanoparticle formulations

Patent 12129223 was granted and assigned to Acuitas Therapeutics on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Acuitas Therapeutics

0

Current Assignee

Acuitas Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Xinyao Du0

Polina Blagojevic0

Julia Gatenyo0

Steven M. Ansell0

Jason Samuel Tan0

Stephen Paul Arns0

Date of Patent

October 29, 2024

0

Patent Application Number

180669540

Date Filed

December 15, 2022

0

Patent Citations

US Patent 6986902 Polyanionic polymers which enhance fusogenicity

0

US Patent 6989264 Methods for generating high titer helper-free preparations of released recombinant AAV vectors

0

US Patent 7013219 Regulation of endogenous gene expression in cells using zinc finger proteins

0

US Patent 7030215 Position dependent recognition of GNN nucleotide triplets by zinc fingers

0

US Patent 7067317 Regulation of angiogenesis with zinc finger proteins

0

US Patent 7070934 Ligand-controlled regulation of endogenous gene expression

0

US Patent 7074596 Synthesis and use of anti-reverse mRNA cap analogues

0

US Patent 7112337 Liposome composition for delivery of nucleic acid

0

...

Patent Primary Examiner

Golam M. Shameem

0

CPC Code

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12129223 Lipids for use in lipid nanoparticle formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.